Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery

NCT01436032 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Laparoscopic Surgery

Interventions

DRUG: N1539
DRUG: N1539
DRUG: N1539
DRUG: Ketorolac Tromethamine
DRUG: Placebo

Sponsor

Alkermes, Inc.